Tilson Financial Group, Inc. Repligen Corp Transaction History

Tilson Financial Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$119.79 - $167.35 $179,685 - $251,025	1,500 New	1,500 $223,000
Q3 2023 Oct 31, 2023	BUY	$138.78 - $176.51 $208,170 - $264,765	1,500 New	1,500 $239,000
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $243,629 - $330,840	1,500 New	1,500 $254,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Tilson Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Tilson Financial Group, Inc. with notifications on news.